DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Macbeth F, Noble S, Evans J. , et al.
Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial.
J Clin Oncol 2016;
34 (05) 488-494
We do not assume any responsibility for the contents of the web pages of other providers.